Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Xiong Feng

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
British Journal of Cancer|May 3, 2018
Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axisJing-Jing Li, Hong-Kun Yin, Dong-Xian Guan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2024
Targeting and monitoring ovarian cancer invasion with an RNAi and peptide delivery systemLiangliang Hao, Natalie Boehnke, Susanna K Elledge, et al.
Cancer Discovery|April 8, 2014
Epithelial-to-mesenchymal transition activates PERK-eIF2α and sensitizes cells to endoplasmic reticulum stressYu-Xiong Feng, Ethan S Sokol, Catherine A Del Vecchio, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2017
SMARCE1 is required for the invasive progression of in situ cancersEthan S Sokol, Yu-Xiong Feng, Dexter X Jin, et al.
Nature Communications|February 9, 2012
EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complexGuo Li, Xiao-Dan Ji, Hong Gao, et al.
Cancer Research|January 27, 2011
EphB3 is overexpressed in non-small-cell lung cancer and promotes tumor metastasis by enhancing cell survival and migrationXiao-Dan Ji, Guo Li, Yu-Xiong Feng, et al.
Nature Communications|January 9, 2025
Alleviation of liver fibrosis by inhibiting a non-canonical ATF4-regulated enhancer program in hepatic stellate cellsLi-Xian Yang, Chuangye Qi, Si Lu, et al.
Oncogene|March 26, 2021
BCL9/BCL9L promotes tumorigenicity through immune-dependent and independent mechanisms in triple negative breast cancerXiaoshuang Wang, Mei Feng, Tengfei Xiao, et al.
Hepatology (Baltimore, Md.)|January 29, 2011
Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse modelYu-Xiong Feng, Tao Wang, Yue-Zhen Deng, et al.
Gut|February 9, 2026
MTFP1 drives pancreatic cancer liver metastatic colonisation by regulating mitochondrial metabolism reprogrammingYang Chen, Gao-Wei Jin, Li-Hong He, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|May 3, 2018
Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axisJing-Jing Li, Hong-Kun Yin, Dong-Xian Guan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2024
Targeting and monitoring ovarian cancer invasion with an RNAi and peptide delivery systemLiangliang Hao, Natalie Boehnke, Susanna K Elledge, et al.
Cancer Discovery|April 8, 2014
Epithelial-to-mesenchymal transition activates PERK-eIF2α and sensitizes cells to endoplasmic reticulum stressYu-Xiong Feng, Ethan S Sokol, Catherine A Del Vecchio, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2017
SMARCE1 is required for the invasive progression of in situ cancersEthan S Sokol, Yu-Xiong Feng, Dexter X Jin, et al.
Nature Communications|February 9, 2012
EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complexGuo Li, Xiao-Dan Ji, Hong Gao, et al.
Cancer Research|January 27, 2011
EphB3 is overexpressed in non-small-cell lung cancer and promotes tumor metastasis by enhancing cell survival and migrationXiao-Dan Ji, Guo Li, Yu-Xiong Feng, et al.
Nature Communications|January 9, 2025
Alleviation of liver fibrosis by inhibiting a non-canonical ATF4-regulated enhancer program in hepatic stellate cellsLi-Xian Yang, Chuangye Qi, Si Lu, et al.
Oncogene|March 26, 2021
BCL9/BCL9L promotes tumorigenicity through immune-dependent and independent mechanisms in triple negative breast cancerXiaoshuang Wang, Mei Feng, Tengfei Xiao, et al.
Hepatology (Baltimore, Md.)|January 29, 2011
Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse modelYu-Xiong Feng, Tao Wang, Yue-Zhen Deng, et al.
Gut|February 9, 2026
MTFP1 drives pancreatic cancer liver metastatic colonisation by regulating mitochondrial metabolism reprogrammingYang Chen, Gao-Wei Jin, Li-Hong He, et al.
Pageof 3